Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamictal as add-on to lithium in bipolar depression
NCT00224510Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2002
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of lamotrigine in bipolar disorder (BD), sponsored by GSK. Started Aug 2002; status: completed.
02
Drugs
lamotrigine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00224510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224510.